Search Results for "Hdac Market Sales"
Original Source: Histone Deacetylase HDAC Inhibitors
Histone deacetylase (HDAC) inhibitors are emerging as a new class of potential anticancer agents for the treatment of solid and hematological malignancies. HDAC inhibition causes acetylated nuclear histones to accumulate in both tumor and normal tissues,...
Matching Channels
Histone Deacetylase HDAC Inhibitors
Histone deacetylase (HDAC) inhibitors are emerging as a new class of potential anticancer agents for the treatment of solid and hematological malignancies. HDAC inhibition causes acetylated nuclear...
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health...
Pfizer is a global pharmaceutical company, the largest in world based on annual sales. In 2009, annual sales were worth $45,448m. Pfizer spend £550m on R&D in the UK alone, and have...
Tumor Necrosis Factor TNF Products
Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...
Matching News
Merck's new mark in HIV HDAC vs. HIV latency Antiretrovirals block active HIV replication but cannot cure patients in part because the virus can hide by integrating its genome into that of long-lived,...
BOSTON--(BUSINESS WIRE)--Nov 20, 2012 - Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced that its select...
Scientists find Achilles’ heel of cancer cells
Several substances inhibiting so-called HDAC enzymes have been studied in trials searching for new anti-cancer drugs in recent years. “Trials have shown that HDAC inhibitors are very effective i...
Tweaking gene expression to repair lungs
(University of Pennsylvania School of Medicine) A healthy lung has some capacity to regenerate itself like the liver. In COPD, these reparative mechanisms fail. HDAC therapies may be useful for COPD,...
Acetylon announces results from selective HDAC 1/2 inhibitor preclinical study on SCD and bT
Acetylon Pharmaceuticals Inc., a leader in targeted epigenetic drug discovery and development for enhanced therapeutic outcomes, today announced results from a preclinical study of a selective histone...
Regional biotech conference to kick off in Md.
More than 750 biotech executives, venture capitalists and government officials are expected at the Mid-Atlantic Biotech Confe -More- TopoTarget HDAC Bull's Eye: 'Spectrum' of Benefit Ahead?...
Discovery of A Chink In The Armor Of Cancer Cells
Several substances inhibiting so-called HDAC enzymes have been studied in trials searching for new anti-cancer drugs in recent years. "Trials have shown that HDAC inhibitors are very effective in arre...
Scientists find Achilles' heel of cancer cells
Several substances inhibiting so-called HDAC enzymes have been studied in trials searching for new anti-cancer drugs in recent years. "Trials have shown that HDAC inhibitors are very effective in arre...
Matching PubMed Articles
Unpredictable market revealed in practice sales.
ABSTRACT: BACKGROUND: The price of antiretroviral drugs (ARVs) in low income countries declined steadily in recent years. This raises concerns about the commercial viability of the market of ARVs in l...
Trends in opioid analgesics sales to community pharmacies and hospitals in Italy (2000-2010).
Background: Opioid consumption data in Italy have been widely studied. However, only aggregate data can be found in the published literature, and differences are expected by distribution setting (comm...
Market uptake of orphan drugs - a European analysis.
What is known and Objective: Variations in market uptake of an orphan drug have important implications with respect to access to care and inequality of treatment. Therefore, the aim of this study w...
The purpose of this study is to investigate the therapeutic effects of a novel histone deacetylase inhibitor (HDACi), NK-HDAC-1, on collagen-induced arthritis (CIA) and pathogenic fibroblast-like syno...
